The United States medical imaging market grew from USD 10.70 Billion in 2025 to USD 11.08 Billion in 2026 and is projected to reach USD 13.81 Billion by 2034, growing at a CAGR of 2.78% during 2026-2034. Chronic disease, an aging population, and AI-enabled systems are supporting demand. In March 2026, GE HealthCare received FDA 510(k) clearance for its Photonova Spectra photon-counting CT system.
Equipment replacement cycles, outpatient imaging growth, and helium-free MRI technology continue to shape purchasing. X-ray imaging systems dominate at 25.0%. Hospitals lead end users at 62.0%. The South commands 35.0% of national market share.
|
Metric |
Value |
|
Base Year Market Size (2025) |
USD 10.70 Billion |
|
Market Size (2026) |
USD 11.08 Billion |
|
Forecast Market Size (2034) |
USD 13.81 Billion |
|
CAGR (2026-2034) |
2.78% |
|
Base Year |
2025 |
|
Historical Period |
2020-2025 |
|
Forecast Period |
2026-2034 |
|
Dominant Product |
X-Ray Imaging Systems (25.0%, 2025) |
|
Dominant End User |
Hospitals (62.0%, 2025) |
|
Leading Region |
South (35.0%, 2025) |
The United States medical imaging market size increased from USD 9.33 Billion in 2020 to USD 10.70 Billion in 2025 and is estimated to reach USD 11.08 Billion in 2026. The market is further expected to grow to USD 12.28 Billion by 2030 and USD 13.81 Billion by 2034. Growth reflects steady equipment upgrades and rising imaging volumes.

To get more information on this market, Request Sample
Ultrasound imaging systems are expected to grow fastest at ~3.3% CAGR, supported by point-of-care use and AI-guided scanning. Diagnostic centers follow at ~3.2% CAGR as imaging continues shifting to lower-cost outpatient settings.

The United States medical imaging market expanded from USD 10.70 Billion in 2025 to an estimated USD 11.08 Billion in 2026. Hospitals and imaging centers are replacing aging equipment with AI-enabled CT, MRI, X-ray, and ultrasound systems that improve image quality, reduce radiation dose, and increase throughput.
Manufacturers are launching photon-counting CT and helium-free MRI platforms. The market is projected to reach USD 13.81 Billion by 2034. X-ray imaging systems at 25.0% lead products. Hospitals at 62.0% lead end users. The South leads at 35.0%.
|
Insight |
Data |
|
Dominant Product |
X-Ray Imaging Systems - 25.0% share (2025) |
|
Dominant End User |
Hospitals - 62.0% market share (2025) |
|
Leading Region |
South - 35.0% share (2025) |
|
Market Opportunity |
Photon-counting CT; helium-free MRI; AI-powered ultrasound; outpatient imaging centers; equipment replacement |
- X-Ray Imaging Systems at 25.0%: X-ray systems dominate because they are the most widely used first-line imaging tool in hospitals, emergency departments, urgent care, and physician offices, with a large installed base requiring regular replacement.
- Hospitals at 62.0%: Hospitals lead because they perform most emergency, inpatient, and complex imaging procedures and operate the largest fleets of CT, MRI, and interventional systems.
- South at 35.0%: The South leads due to its large and growing population, major health systems in Texas and Florida, and rising demand from older adults.
Medical imaging includes CT scanners, X-ray systems, MRI systems, ultrasound, nuclear imaging, and mammography used to diagnose, monitor, and guide treatment of diseases. These technologies are essential across emergency, oncology, cardiology, neurology, and women’s health. Imaging also guides interventional procedures and surgical planning.

Systems are increasingly connected to PACS, EHRs, and AI software. Connectivity enables remote support and data-driven fleet management.
The industry ecosystem links component suppliers, system manufacturers, distributors, service providers, IT and AI partners, regulators, payers, and end users. Macroeconomic factors include healthcare spending, reimbursement rates, capital budgets, and demographic trends, all of which shape demand. FDA clearances and CMS policies strongly influence product launches and purchasing decisions.
Capital budgets in hospitals depend on financial performance and patient volumes. Interest rates and financing costs also influence equipment purchasing decisions.

To evaluate market opportunities, Request Sample

Next-generation CT offers higher resolution and tissue characterization. In April 2026, Philips received FDA 510(k) clearance for its Spectral CT Verida system.
Manufacturers are introducing sealed-magnet MRI systems that reduce helium use, lower installation costs, and expand access. Lower helium use also reduces the need for quench pipes and costly site modifications. Smaller magnet designs make MRI more practical in outpatient and community settings.
These systems expand MRI access in smaller hospitals and imaging centers. Lower installation costs make MRI more accessible in rural regions. Mobile MRI units also serve communities without permanent scanners. These services improve access for rural patients.
AI tools reduce scan times, improve image quality, and automate routine tasks for technologists and radiologists. Automated positioning and protocol selection reduce variability between operators. AI also supports faster reporting and fewer repeat scans. AI also helps detect findings that may be missed during busy shifts.
Clinical validation of AI tools remains important for adoption. FDA clearances for AI tools continue to increase each year. Radiology accounts for the largest share of these clearances.
Imaging is shifting to outpatient centers and bedside settings, supported by compact and portable systems. Mobile imaging services also bring scans to nursing homes and rural communities. Point-of-care imaging improves access and speeds diagnosis. These settings benefit from easy-to-use systems with AI guidance.
Training requirements for portable systems are typically lower. Handheld devices are increasingly connected to cloud-based image storage. This allows easy review and sharing of point-of-care images.
The United States medical imaging value chain spans components and materials, system manufacturing, distribution and sales, installation and integration, imaging services, and maintenance and upgrades. Value is shifting toward software, AI, and lifecycle services. Distribution and installation require close coordination with hospital facilities and IT teams.
Imaging services generate revenue and clinical value for providers. Each stage of the chain influences uptime, quality, and patient experience. Manufacturers increasingly offer end-to-end solutions across the chain. Partnerships with IT companies support integrated imaging workflows. These partnerships also accelerate deployment of cloud and AI tools.
|
Stage |
Key Participants |
|
Components & Materials |
Detector, magnet, tube, and transducer suppliers |
|
System Manufacturing |
CT, MRI, X-ray, ultrasound, nuclear, and mammography makers |
|
Distribution & Sales |
Direct sales teams, distributors, and refurbishers |
|
Installation & Integration |
Site planners, installers, and PACS integrators |
|
Imaging Services |
Hospitals, diagnostic centers, and academic institutes |
|
Maintenance & Upgrades |
OEM service teams and independent service organizations |
Maintenance and upgrades is the most consequential stage of the chain. Service contracts and software upgrades keep systems productive and generate recurring revenue for manufacturers. Independent service organizations also compete for maintenance contracts on older systems. Software upgrades extend the life and capabilities of installed equipment.
Remote monitoring allows service teams to fix issues before failures occur. Predictive maintenance reduces downtime and improves patient scheduling. Uptime guarantees are common in large service contracts. Service performance is a major factor in contract renewals.
Photon-counting detectors measure individual X-ray photons, improving resolution and enabling material differentiation. This improves visualization of small vessels, plaque, and lesions. Spectral imaging also reduces the need for additional scans. Lower radiation doses are especially important for pediatric patients.
Photon-counting systems are expected to expand from academic centers to community hospitals. Pricing and reimbursement will influence the pace of adoption. Early clinical results are encouraging broader interest from cardiology and oncology departments.
Sealed magnets and deep learning reconstruction reduce helium use and shorten MRI scan times. Faster scans improve patient comfort and increase daily capacity. Helium-free magnets lower operating costs and environmental impact. Compact designs reduce space requirements in busy facilities. AI-driven protocols simplify complex exams for technologists.
Faster exams improve patient experience and access. Shorter scan times also allow imaging departments to reduce wait lists for MRI and CT appointments.
AI guidance automates ultrasound measurements, while cloud-based enterprise imaging connects images across care settings. Enterprise imaging platforms support remote reading and collaboration among radiologists. Cloud imaging reduces on-site storage needs and supports AI deployment. Interoperability standards support image sharing between hospitals. Zero-footprint viewers enable access from any device.
This supports teleradiology and after-hours coverage. Teleradiology groups help hospitals manage overnight and weekend reading demand, while cloud platforms make it easier to distribute studies to subspecialty radiologists across different states.
The report covers the following segments:
|
Segment Category |
Leading Segment |
Market Share |
Year |
|
Product |
X-Ray Imaging Systems |
25.0% |
2025 |
|
Application |
🔒 |
🔒 |
2025 |
|
End User |
Hospitals |
62.0% |
2025 |
|
Region |
South |
35.0% |
2025 |
X-ray imaging systems lead at 25.0% (2025). They are widely used for first-line diagnosis in hospitals, emergency departments, and clinics. Digital radiography has largely replaced film and computed radiography in hospitals. Mobile and portable X-ray systems are growing in hospital use. Dose reduction technology improves patient safety.

To access detailed market analysis, Request Sample
Fluoroscopy and C-arm systems support surgical and interventional procedures.
CT scanners at 22.0% grow at ~3.0% CAGR, MRI systems at 20.0% at ~2.9%, and ultrasound at 18.0% fastest at ~3.3%. Nuclear imaging at 8.0% grows at ~2.9% and mammography at 7.0% at ~2.4%. Theranostics and PET imaging are supporting demand for nuclear imaging systems.
Mammography demand is supported by breast cancer screening programs and 3D tomosynthesis. Mammography systems increasingly include AI detection tools. Ultrasound demand is supported by obstetrics, cardiology, and point-of-care use.
Hospitals lead at 62.0% (2025). They perform most emergency, inpatient, and complex imaging procedures. Large health systems standardize equipment across multiple hospitals through enterprise agreements.

Diagnostic centers at 30.0% grow fastest at ~3.2% CAGR, driven by outpatient imaging growth. Academic institutes and research organizations at 8.0% grow at ~2.7%, supported by research funding. These institutions often adopt the most advanced systems first. Research use supports demand for high-field MRI and PET/MR systems.
Research collaborations with manufacturers support innovation and clinical validation. Academic centers also train the next generation of radiologists.
|
Region |
Share (2025) |
Key United States Medical Imaging Market Drivers & Characteristics |
|
South |
35.0% |
Large, aging population and major health systems in Texas and Florida. |
|
West |
26.0% |
Large integrated systems and early adoption of advanced technology. |
|
Midwest |
21.0% |
Major academic medical centers and regional hospital networks. |
|
Northeast |
18.0% |
Dense academic hospitals and research institutions. |
The South's 35.0% market leadership reflects its large and growing population, major health systems in Texas and Florida, and rising demand from older adults. The West's 26.0% reflects large integrated delivery networks and early adoption of advanced imaging technology. California hosts many leading academic medical centers and imaging innovators.

The Midwest's 21.0% reflects major academic medical centers and regional hospital networks. The Northeast's 18.0% is the smallest share, but dense academic hospitals and research institutions support strong demand for advanced systems. Boston, New York, and Philadelphia host leading academic imaging programs. The region also has high imaging utilization rates.
Older equipment replacement is a key driver in the region. Strong hospital networks support adoption of advanced systems.
The United States medical imaging market is led by global manufacturers with broad modality portfolios, alongside specialists in women’s health, X-ray, and ultrasound. Competition centers on image quality, AI capabilities, dose reduction, service, and total cost of ownership. Strong service and uptime guarantees are important purchasing factors.
Group purchasing organizations influence pricing and vendor selection. Long-term service contracts create stable revenue for manufacturers. Vendor reputation and reliability strongly influence buyer loyalty.
|
Company |
Key Brands |
Market Position |
Core Strength |
| GE HealthCare | Revolution CT, SIGNA MRI, Photonova | Market Leader | Broad modality portfolio and installed base. |
| Siemens Medical Solutions USA, Inc. | Naeotom Alpha, Magnetom, Biograph | Market Leader | Leader in CT and photon-counting technology. |
| Koninklijke Philips N.V. | Spectral CT, BlueSeal, EPIQ | Strong Challenger | Spectral CT and helium-free MRI. |
| Canon Medical Systems, USA | Aquilion, Vantage, Aplio | Strong Challenger | CT, MRI, and ultrasound portfolio. |
| Hologic, Inc. | 3Dimensions, Genius AI | Innovator | Leader in mammography and breast imaging. |
| Carestream Health | DRX systems | Niche Player | Digital radiography systems. |
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | Resona, TE Air | Niche Player | Cost-effective ultrasound systems. |
The most important competitive dynamic is the race to commercialize photon-counting CT, helium-free MRI, and AI-enabled workflows. Vendors with strong service networks and installed bases are best placed to win replacement cycles. Smaller vendors compete through price, specialty focus, and flexible service.
Partnerships with AI developers are increasingly common among leading vendors. Vendors also compete on sustainability and energy efficiency. Environmental goals are becoming part of hospital procurement criteria.
GE HealthCare is a leading medical technology company offering CT, MRI, X-ray, ultrasound, nuclear imaging, and mammography systems along with imaging agents and digital solutions.
Siemens Medical Solutions USA, Inc. is the U.S. arm of Siemens Healthineers, offering CT, MRI, molecular imaging, X-ray, and ultrasound systems.
Koninklijke Philips N.V. is a global health technology company with strengths in CT, MRI, ultrasound, and image-guided therapy.
The United States medical imaging market is highly concentrated, with a few global manufacturers holding most CT, MRI, and molecular imaging sales, while ultrasound and X-ray are more competitive.
Market concentration remains stable as large vendors win long-term enterprise agreements, while specialists compete in mammography, digital radiography, and portable ultrasound. Refurbished equipment also provides lower-cost options for smaller providers. Third-party service providers compete strongly in maintenance. Pricing pressure is strongest in mature modalities such as X-ray.
Advanced modalities remain dominated by established global brands.
Ultrasound imaging systems (~3.3% CAGR through point-of-care use), diagnostic centers (~3.2% CAGR through outpatient growth), the South (~3.1% CAGR through population growth), and CT scanners (~3.0% CAGR through photon-counting adoption) represent the highest-growth investment areas through 2034.
AI-enabled imaging software and helium-free MRI are among the most promising opportunities, improving efficiency and lowering costs. Imaging center expansion is another attractive area for investment.
The United States medical imaging market is projected to grow from USD 10.70 Billion in 2025 to USD 11.08 Billion in 2026, reaching USD 13.81 Billion by 2034, registering a CAGR of 2.78% during 2026-2034.
The anchor value of USD 12.28 Billion in 2030 marks a point at which AI reconstruction should be standard across modalities. By then, photon-counting CT should be widely adopted in large hospitals. Outpatient centers should account for a larger share of imaging procedures.
Three structural forces define United States medical imaging market growth through 2034 demographic demand; technology replacement; and outpatient expansion. Together, these forces support steady growth across products and regions. Replacement demand will provide a stable base for market revenue.
AI software is expected to become a larger part of vendor revenue. Service and digital solutions will further support recurring income.
Primary research comprised structured interviews with industry stakeholders, including imaging equipment manufacturers, distributors, radiologists, hospital administrators, and imaging center operators across the United States.
Secondary research covered company press releases, FDA clearances, CMS data, and industry reports. Over 50 credible secondary sources were reviewed, compared, and cross-checked for accuracy and consistency across datasets.
Market revenue forecasts were developed using an installed base and replacement model: system shipments by product, end user, and region multiplied by average selling prices, with segment results aggregated to total market value.
Assumptions were validated through detailed discussions with experienced industry experts, radiology leaders, and equipment suppliers across the United States.
| Report Features | Details |
|---|---|
| Base Year of the Analysis | 2025 |
| Historical Period | 2020-2025 |
| Forecast Period | 2026-2034 |
| Units | Billion USD |
| Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
| Products Covered | CT Scanners, X-Ray Imaging Systems, MRI Systems, Ultrasound Imaging Systems, Nuclear Imaging Systems, Mammography Systems |
| Applications Covered | Obstetrics and Gynecology Health, Orthopedics and Musculoskeletal, Neuro and Spine, Cardiovascular and Thoracic, General Imaging, Breast Health, Others |
| End Users Covered | Hospitals, Diagnostic Centers, Academic Institutes and Research Organizations |
| Regions Covered | Northeast, Midwest, South, West |
| Companies Covered | GE HealthCare, Siemens Medical Solutions USA, Inc., Koninklijke Philips N.V., Canon Medical Systems, USA, Hologic, Inc., Carestream Health, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., etc. |
| Customization Scope | 10% Free Customization |
| Post-Sale Analyst Support | 10-12 Weeks |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The market size is estimated at USD 11.08 Billion in 2026, supported by aging demographics and equipment upgrades.
The market grows at 2.78% CAGR during 2026-2034, reaching USD 13.81 Billion by 2034.
X-ray imaging systems lead at 25.0%, owing to wide first-line diagnostic use.
Hospitals lead at 62.0%, performing most emergency and complex imaging.
Leading companies include GE HealthCare, Siemens Medical Solutions USA, Inc., Koninklijke Philips N.V., Canon Medical Systems, USA, Hologic, Inc., Carestream Health, and Shenzhen Mindray Bio-Medical Electronics Co., Ltd., among others.
The market is projected to reach approximately USD 12.28 Billion by 2030.
Key trends include photon-counting CT, helium-free MRI, AI reconstruction, and outpatient imaging growth.
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
3 reports
5 reports
8 reports
10 reports